<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03500796</url>
  </required_header>
  <id_info>
    <org_study_id>56-2/2018</org_study_id>
    <nct_id>NCT03500796</nct_id>
  </id_info>
  <brief_title>Combined Amniotic Membrane and Platelet Rich Plasma Clot for Management of Central Corneal Perforation</brief_title>
  <official_title>Combined Amniotic Membrane and Platelet Rich Plasma Clot for Management of Central Corneal Perforation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Use of amniotic membrane(AMT) and platelet rich plasma (PRP) clot for closure of central&#xD;
      corneal perforation&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Use of amniotic membrane and platelet rich plasma clot for closure of central corneal&#xD;
      perforation either post infective or posttraumatic&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 15, 2018</start_date>
  <completion_date type="Actual">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Closure of the corneal wound</measure>
    <time_frame>3 months</time_frame>
    <description>sealing of the edges corneal gap, with formation of scar tissue</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Corneal Perforation</condition>
  <arm_group>
    <arm_group_label>Corneal perforation patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients who had/impeding corneal perforation due to melting of the cornea after infection with a corneal pathogen (bacterial or viral), with no previous surgical intervention.&#xD;
Patients will undergo:&#xD;
Platelet rich plasma clot implantation Wound closure with amniotic membrane</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Platelet rich plasma clot implantation</intervention_name>
    <description>Implantation of a platelet rich plasma clot, which is created from the plasma of the patients, and refrigerated to be inserted under the sealing amniotic membrane</description>
    <arm_group_label>Corneal perforation patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Wound closure with amniotic membrane</intervention_name>
    <description>Closure of the corneal perforation with a synthetic amniotic membrane with a 2 mm safety margin</description>
    <arm_group_label>Corneal perforation patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  central corneal perforation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  active infection&#xD;
&#xD;
          -  posterior segment pathology&#xD;
&#xD;
          -  non seeing eye&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed A Abdelghany, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant professor of Ophthalmology, Faculty of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine</name>
      <address>
        <city>Minya</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 23, 2018</study_first_submitted>
  <study_first_submitted_qc>April 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 18, 2018</study_first_posted>
  <last_update_submitted>May 17, 2021</last_update_submitted>
  <last_update_submitted_qc>May 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>Ahemd Abdelghany</investigator_full_name>
    <investigator_title>Lecturer of Ophthalmology, Faculty of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Perforation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>steps of technique and results</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

